Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Impact of Non-Exudative Type 1 MNV on AMD Progression

View source ↗

Summary

This University of Utah–sponsored trial investigates whether non-exudative type 1 macular neovascularization influences the progression of age-related Macular D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Age-Related Macular Degeneration, Neovascularization, Choroidal | Status: ACTIVE_NOT_RECRUITING